Bhardwaj Kritika, Roy Abhishek, Guha Lahanya, Kumar Hemant
Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Ahmedabad (NIPER-A), Palaj, Gandhinagar, Gujarat 382355, India.
ACS Pharmacol Transl Sci. 2024 Dec 4;7(12):3879-3888. doi: 10.1021/acsptsci.4c00423. eCollection 2024 Dec 13.
The malfunctioning of microtubules is highly correlated with neurodegenerative disorders such as Parkinson's disease (PD), although whether it is a cause or an effect of neurodegeneration is yet unknown. Lin-11, Isl-1, and Mec-3 kinases (LIMKs), being one of the important kinases, regulate the neuronal cytoskeleton by controlling the phosphorylation of the cofilin/actin-depolymerizing factor. Recently, we showed that upregulation of phosphorylated LIMK1 (p-LIMK1) affects the microtubule dynamics in a central nervous system traumatic injury. The goal of this study is to correlate the expression of LIMK1 with dopaminergic neuron death in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of PD, one of the well-established subacute models of PD, where the neurotoxin acts via inhibition of mitochondrial complex I of the electron transport chain. Herein, we found that LIMK1 expression was increased and correlated to dopaminergic neuronal death. Finally, we demonstrated that the treatment with LIMK inhibitor BMS-5 significantly reversed the neurodegeneration, along with an upregulation of the dynamic tubulins, indicating the relevance of LIMKs and microtubule dynamics in neurodegeneration. Therefore, targeting the microtubules, an integral part of the neuronal cytoskeleton and neurite formation, can be a promising strategy to combat degeneration of dopaminergic neurons.
微管功能异常与帕金森病(PD)等神经退行性疾病高度相关,尽管它是神经退行性变的原因还是结果尚不清楚。作为重要激酶之一的Lin-11、Isl-1和Mec-3激酶(LIMKs),通过控制丝切蛋白/肌动蛋白解聚因子的磷酸化来调节神经元细胞骨架。最近,我们发现磷酸化LIMK1(p-LIMK1)的上调会影响中枢神经系统创伤性损伤中的微管动力学。本研究的目的是在1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)帕金森病模型(一种成熟的亚急性帕金森病模型,其中神经毒素通过抑制电子传递链的线粒体复合物I起作用)中,将LIMK1的表达与多巴胺能神经元死亡相关联。在此,我们发现LIMK1表达增加并与多巴胺能神经元死亡相关。最后,我们证明用LIMK抑制剂BMS-5治疗可显著逆转神经退行性变,同时上调动态微管蛋白,表明LIMKs和微管动力学在神经退行性变中的相关性。因此,针对微管(神经元细胞骨架和神经突形成的一个组成部分)可能是对抗多巴胺能神经元变性的一种有前景的策略。